Clinical Trials and Cancer Immunotherapy: Accessing Promising Treatments Myth-busting patient participation in medical studies Clinical trials are essential to bringing promising new therapies to patients, often for the first time or in new combinations with other treatments. What is a clinical trial? What are common misconceptions about clinical trials? How can you access and enroll in a cancer immunotherapy clinical trial? How has the COVID-19 pandemic changed patient participation in cancer clinical trials? These are just few of the questions that Dr. Peter Fecci, Professor of Neurosurgery, Pathology, Immunology, and Biomedical Engineering at Duke University, will address during this informative and myth-busting session. Following his talk, you’ll have an opportunity to ask your questions about clinical trials during a live Q&A session. Patient Perspectives: Immunotherapy and Clinical Trial Experiences Bladder Cancer Immunotherapy Gynecologic Cancer Immunotherapy Liver Cancer Immunotherapy Skin Cancer and Melanoma Immunotherapy Understanding and Overcoming Barriers to Accessing Cancer Care Blood Cancer Immunotherapy Breast Cancer Immunotherapy Colorectal Cancer Immunotherapy Kidney Cancer Immunotherapy Lung Cancer Immunotherapy Pancreatic Cancer Immunotherapy Prostate Cancer Immunotherapy Intro to CRI Cancer Immunotherapy Basics: Harnessing Our Immune System to Fight Cancer Go back to event page Go back Hosts Tamron Hall Award-Winning TV Host, Journalist, Executive Producer, and Philanthropist CRI Experts Julie Brahmer, MD Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Andrea Cercek, MD Memorial Sloan Kettering Cancer Center Luis Diaz Jr., MD Memorial Sloan Kettering Cancer Center Peter E. Fecci, MD, PhD Duke Cancer Center, DukeHealth, and Duke University Lawrence Fong, MD UCSF Helen Diller Family Comprehensive Cancer Center Matthew D. Galsky, MD The Tisch Cancer Institute Sangeeta Goswami, MD, PhD The University of Texas MD Anderson Cancer Center Elizabeth Ann Mittendorf, MD, PhD Dana-Farber/Harvard Cancer Center Kunle Odunsi, MD, PhD University of Chicago Medicine Comprehensive Cancer Center Joseph E. Ravenell, MD Perlmutter Cancer Center NYU Langone Health Marcel van den Brink, MD, PhD Memorial Sloan Kettering Cancer Center Ana I. Velázquez Mañana, MD MSc UCSF Helen Diller Family Comprehensive Cancer Center Robert H. Vonderheide, MD, DPhil University of Pennsylvania Health System Jennifer Wargo, MD, MMSc The University of Texas MD Anderson Cancer Center Jeffrey S. Weber, MD, PhD Perlmutter Cancer Center NYU Langone Health Theodore H. Welling, MD Perlmutter Cancer Center NYU Langone Health CRI ImmunoAdvocates LaToya Bolds-Johnson, PA-C, CAQ-EM Breast Cancer Advocate & Thriver Stephen Estrada Long-term Survivor of Stage 4 Colorectal Cancer Stephanie Gangi Breast Cancer Navigator Sunshine Pegues Lung Cancer Veteran John White Prostate Cancer Veteran CRI Moderators Brian Brewer Cancer Research Institute Sponsors Gold Silver Contributor Friend Host Institutions Request a clinical trials orientation appointment Request Questions? Contact[email protected]
